Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió acceptadaData de publicació
Tots els drets reservats
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/109130
(−)-UB006: A new fatty acid synthase inhibitor and cytotoxic agent without anorexic side effects
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
C75 is a synthetic anticancer drug that inhibits fatty acid synthase (FAS) and shows a potent anorexigenic side effect. In order to find new cytotoxic compounds that do not impact food intake, we synthesized a new family of C75 derivatives. The most promising anticancer compound among them was UB006 ((4SR,5SR)-4-(hydroxymethyl)-3-methylene-5-octyldihydrofuran-2(3H)-one). The effects of this compound on cytotoxicity, food intake and body weight were studied in UB006 racemic mixture and in both its enantiomers separately. The results showed that both enantiomers inhibit FAS activity and have potent cytotoxic effects in several tumour cell lines, such as the ovarian cell cancer line OVCAR-3. The (−)-UB006 enantiomer's cytotoxic effect on OVCAR-3 was 40-fold higher than that of racemic C75, and 2- and 38-fold higher than that of the racemic mixture and its opposite enantiomer, respectively. This cytotoxic effect on the OVCAR-3 cell line involves mechanisms that reduce mitochondrial respiratory capacity and ATP production, DDIT4/REDD1 upregulation, mTOR activity inhibition, and caspase-3 activation, resulting in apoptosis. In addition, central and peripheral administration of (+)-UB006 or (−)-UB006 into rats and mice did not affect food intake or body weight. Altogether, our data support the discovery of a new potential anticancer compound (−)-UB006 that has no anorexigenic side effects.
Matèries (anglès)
Citació
Citació
MAKOWSKI, Kamil, MIR BONNÍN, Joan francesc, MERA NANÍN, Paula, ARIZA PIQUER, Xavier, ASINS MUÑOZ, Guillermina, HEGARDT, Fausto, HERRERO RODRÍGUEZ, Laura, GARCÍA GÓMEZ, Jordi, SERRA I CUCURULL, Dolors. (−)-UB006: A new fatty acid synthase inhibitor and cytotoxic agent without anorexic side effects. _European Journal of Medicinal Chemistry_. 2017. Vol. 131, núm. 207-221. [consulta: 21 de gener de 2026]. ISSN: 0223-5234. [Disponible a: https://hdl.handle.net/2445/109130]